Product information and disease descriptionProduct descriptionProduct information
Access and distribution
10 evidence topics · 5 sources
Risk Evaluation and Mitigation Strategy expected, modeled on the Spravato REMS
Prescriber and provider training
Administration at a certified treatment center with session monitoring
Monitoring staffing: one primary monitor and closed-circuit television, two healthcare providers in total
Treatment-center network: more than 8,500 interventional psychiatry centers
Distribution channels: specialty pharmacy and buy-and-bill, reimbursed through the pharmacy benefit
Monitoring billed through CPT Category III codes for psychedelic drug monitoring
“CPTIII codes specifically for psychedelics” (opens the source at this quote in a new tab)
“billed by the hour through medical benefit” (opens the source at this quote in a new tab)